Zobrazeno 1 - 10
of 37
pro vyhledávání: '"HIV/tuberculosis co-infection"'
Publikováno v:
Monaldi Archives for Chest Disease (2024)
The dual burden of human immunodeficiency virus (HIV) and tuberculosis (TB) impacts people living with HIV (PLHIV) coinfected with TB. Although some primary studies have been reported on the burden of extrapulmonary TB (EPTB) among PLHIV in Southeast
Externí odkaz:
https://doaj.org/article/ff287438ffa8445f93539b61619e671c
Autor:
Ashwini Shete, Manisha Ghate, Hiroko Iwasaki-Hozumi, Sandip Patil, Pallavi Shidhaye, Takashi Matsuba, Gaowa Bai, Pratiksha Pharande, Toshio Hattori
Publikováno v:
Reports, Vol 7, Iss 3, p 61 (2024)
We asked if SARS-CoV-2 seropositivity in HIV/TB co-infected patients plays a role in precipitating active tuberculosis in HIV-infected individuals and alters inflammatory status. A prospective study was conducted on HIV/TB co-infected patients presen
Externí odkaz:
https://doaj.org/article/948cbae8e7e6461a9d6647a59b6e709d
Publikováno v:
Portuguese Journal of Public Health, Vol 39, Iss 3, Pp 163-169 (2022)
Introduction: Portugal is one of the countries in Western Europe with the highest prevalence of tuberculosis (TB) and human immunodeficiency virus (HIV). The prevalence among migrants is estimated to be higher than among non-migrants, which suggests
Externí odkaz:
https://doaj.org/article/3c2b8764634d4d44bca5ef7f982465e8
Autor:
M. V. Sinitsyn, M. V. Kalinina, E. M. Belilovskiy, A. S. Galstyan, M. N. Reshetnikov, D. V. Plotkin
Publikováno v:
Терапевтический архив, Vol 92, Iss 8, Pp 86-94 (2020)
Aim. Study of the current state of problems of treatment of patients with tuberculosis based on literature data and their own experience. Materials and methods. In the Russian Federation, the number and proportion of patients with co-infection wit
Externí odkaz:
https://doaj.org/article/404ece15b950409d9cdc18df6598bbec
Autor:
Seni Kouanda, Henri Gautier Ouedraogo, Kadari Cisse, Tegwinde Rebeca Compaoré, Giorgia Sulis, Serge Diagbouga, Alberto Roggi, Grissoum Tarnagda, Paola Villani, Lassana Sangare, Jacques Simporé, Mario Regazzi, Alberto Matteelli
Publikováno v:
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background This study aimed to assess the pharmacokinetic profile of 150 mg rifabutin (RBT) taken every other day (every 48 h) versus 300 mg RBT taken every other day (E.O.D), both in combination with lopinavir/ritonavir (LPV/r), in adult pa
Externí odkaz:
https://doaj.org/article/75183d59095c4604b5dbabaabc318392
Autor:
Glaycy Celeste Monteiro Gomes, Alline Bianka Cutrim Serra, Dayane Maria Ribeiro Da Silva, Bombarda, Fabio, Gilson De Souza Pereira, Da Silva Correa, Ingrid Dias, Da Silva Costa, Lana Dresley, Layza Vitória Bezerra Maia, Fernandes, Natércia Brígido Linhares, Santos, Raquel Carvalho Dos, Da Silva Pereira, Sabrina, Barroso, Teresa Kariny Pontes
A co-infecção HIV/tuberculose (TB) é um problema de saúde pública crescente em todo o mundo, principalmente em países em desenvolvimento, devido à interação sinérgica entre os dois agentes infecciosos, o vírus da imunodeficiência humana (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cbbf6285bfa9c9bcf651eaccb575aaf
Publikováno v:
Portuguese Journal of Public Health v.39 n.3 2021
Portuguese Journal of Public Health, Vol 39, Iss 3, Pp 163-169 (2022)
Portuguese Journal of Public Health, Vol 39, Iss 3, Pp 163-169 (2022)
Introduction: Portugal is one of the countries in Western Europe with the highest prevalence of tuberculosis (TB) and human immunodeficiency virus (HIV). The prevalence among migrants is estimated to be higher than among non-migrants, which suggests
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69e19280da91cac90f466ff226da6e70
http://scielo.pt/scielo.php?script=sci_arttext&pid=S2504-31452021000300163
http://scielo.pt/scielo.php?script=sci_arttext&pid=S2504-31452021000300163
Autor:
Barbara Castelnuovo, Christine Sekaggya-Wiltshire, Marisa B. Kaelin, Marco Notarfrancesco, Jan Fehr
Publikováno v:
SAGE Open Medical Case Reports, Vol 9 (2021)
SAGE Open Medical Case Reports
SAGE Open Medical Case Reports
Among new tuberculosis cases in Uganda, 10.3% are drug-resistant and 43% occur in people living with HIV. Both resistance and HIV–tuberculosis co-infection lead to unfavourable tuberculosis treatment outcomes. In this case series, we followed up ei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf4a93b193ebbed3a543259046aa79ec
https://doi.org/10.5167/uzh-214090
https://doi.org/10.5167/uzh-214090
Autor:
Gaowa Bai, Sandip Patil, Annapurna Vyakarnam, Vishwanath Pujari, Rashmi Govind Virkar, Shubhangi Bichare, Toshio Hattori, Madhuri Thakar, Raman R. Gangakhedkar, Toshiro Niki, Ashwini Shete, Manisha Ghate
Publikováno v:
Frontiers in Microbiology, Vol 11 (2020)
Frontiers in Microbiology
Frontiers in Microbiology
Galectin-9 (Gal-9) and osteopontin (OPN) play immunomodulatory roles in tuberculosis and HIV infections. Evaluation of their levels as well as their interplay with different pro-inflammatory cytokines is critical to understand their role in immunopat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cb4d8cd8da64e9b153a147c93707ff6
https://www.frontiersin.org/article/10.3389/fmicb.2020.01685/full
https://www.frontiersin.org/article/10.3389/fmicb.2020.01685/full
Autor:
Tegwindé Rebeca Compaore, Paola Villani, Alberto Matteelli, Giorgia Sulis, Jacques Simpore, Serge Diagbouga, Alberto Roggi, Seni Kouanda, Mario Regazzi, Lassana Sangaré, Grissoum Tarnagda, Henri Gautier Ouedraogo, Kadari Cisse
Publikováno v:
BMC Infectious Diseases
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-10 (2020)
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-10 (2020)
BackgroundThis study aimed to assess the pharmacokinetic profile of 150 mg rifabutin (RBT) taken every other day (every 48 h) versus 300 mg RBT taken every other day (E.O.D), both in combination with lopinavir/ritonavir (LPV/r), in adult patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd59ae11bc09b83e9ec940144203e1b5
http://europepmc.org/articles/PMC7318514
http://europepmc.org/articles/PMC7318514